State Street’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $26.4M | Buy |
|
|||||
|
2025
Q2 | $28.8M | Sell |
|
|||||
|
2025
Q1 | $34M | Buy |
|
|||||
|
2024
Q4 | $52.8M | Buy |
|
|||||
|
2024
Q3 | $53.3M | Sell |
|
|||||
|
2024
Q2 | $56.5M | Sell |
|
|||||
|
2024
Q1 | $40.1M | Buy |
|
|||||
|
2023
Q4 | $9.51M | Sell |
|
|||||
|
2023
Q3 | $13.9M | Sell |
|
|||||
|
2023
Q2 | $19.2M | Sell |
|
|||||
|
2023
Q1 | $19.8M | Sell |
|
|||||
|
2022
Q4 | $27.5M | Buy |
|
|||||
|
2022
Q3 | $30.1M | Buy |
|
|||||
|
2022
Q2 | $26.8M | Sell |
|
|||||
|
2022
Q1 | $32.3M | Buy |
|
|||||
|
2021
Q4 | $45.1M | Sell |
|
|||||
|
2021
Q3 | $48.9M | Sell |
|
|||||
|
2021
Q2 | $49.3M | Buy |
|
|||||
|
2021
Q1 | $42.8M | Buy |
|
|||||
|
2020
Q4 | $14.8M | Buy |
|
|||||
|
2020
Q3 | $4.6M | Buy |
|